Clinical Trial Update: Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study

View source ↗

Summary

This clinical trial update reports a retrospective cohort analysis examining the optimal sequence of surufatinib and somatostatin analog therapy in neuroendocri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• Lanreotide (lanreotide)
• OCTREOTIDE (OCTREOTIDE ACETATE)
• Pasireotide (pasireotide)
• Surufatinib (Surufatinib)

Snippet

Sponsor: West China Hospital | Conditions: Neuroendocrine Tumors | Status: ACTIVE_NOT_RECRUITING